T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects Meeting Abstract
| Authors: | Hirschhorn-Cymerman, D.; Ricca, J.; Gasmi, B.; De Henau, O.; Mangarin, L.; Budhu, S.; Li, Y.; Cortez, C.; Liu, C.; Zappasodi, R.; Houghton, S.; Betof, A.; Panageas, K.; Lacuoture, M.; Hollmann, T.; Albrengues, J.; Egeblad, M.; Merghoub, T.; Wolchok, J. |
| Abstract Title: | T cell immunotherapies trigger innate immunity and aseptic inflammation leading to potent anti-tumor and off-targets effects |
| Meeting Title: | 33rd Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2018) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 6 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Nov 7-11 |
| Meeting Location: | Washington, DC |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2018-11-06 |
| Start Page: | 115 |
| Language: | English |
| PMCID: | PMC6220479 |
| PUBMED: | 30400822 |
| DOI: | 10.1186/s40425-018-0423-x |
| PROVIDER: | manual |
| Notes: | Meeting Abstract: P521 -- Mario Lacouture's last name and Travis Hollmann's first name were misspelled on the original publication |
